相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。SAFETY AND EFFECT ON ROD FUNCTION OF ACU-4429, A NOVEL SMALL-MOLECULE VISUAL CYCLE MODULATOR
Ryo Kubota et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2012)
Tyrosine-Mutant AAV8 Delivery of Human MERTK Provides Long-Term Retinal Preservation in RCS Rats
Wen-Tao Deng et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2012)
Ocular Hypotensive Effect of the Rho Kinase Inhibitor AR-12286 in Patients With Glaucoma and Ocular Hypertension
Robert D. Williams et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2011)
A Randomized Trial of Brimonidine Versus Timolol in Preserving Visual Function: Results From the Low-pressure Glaucoma Treatment Study
Theodore Krupin et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2011)
Assessing Susceptibility to Age-Related Macular Degeneration With Genetic Markers and Environmental Factors
Yuhong Chen et al.
ARCHIVES OF OPHTHALMOLOGY (2011)
Monitoring intraocular pressure for 24 h
John H. K. Liu et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2011)
A Phase 2, Randomized, Dose-Response Trial of Taprenepag Isopropyl (PF-04217329) Versus Latanoprost 0.005% in Open-Angle Glaucoma and Ocular Hypertension
Ronald A. Schachar et al.
CURRENT EYE RESEARCH (2011)
Drug delivery to the posterior segment of the eye
Thilini Rasika Thrimawithana et al.
DRUG DISCOVERY TODAY (2011)
Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating Prostaglandin F2α agonist, in preclinical models
Achim H. P. Krauss et al.
EXPERIMENTAL EYE RESEARCH (2011)
Ocular drug delivery - a look towards nanobioadhesives
Lisa C. du Toit et al.
EXPERT OPINION ON DRUG DELIVERY (2011)
Common genetic variants associated with open-angle glaucoma
Wishal D. Ramdas et al.
HUMAN MOLECULAR GENETICS (2011)
Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons
Wendi S. Lambert et al.
MOLECULAR NEURODEGENERATION (2011)
Preclinical Safety Evaluation of AAV2-sFLT01-A Gene Therapy for Age-related Macular Degeneration
Timothy K. MacLachlan et al.
MOLECULAR THERAPY (2011)
DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration
Hiroki Kaneko et al.
NATURE (2011)
Complement factor H binds malondialdehyde epitopes and protects from oxidative stress
David Weismann et al.
NATURE (2011)
Genome-wide association study identifies susceptibility loci for open angle glaucoma at TMCO1 and CDKN2B-AS1
Kathryn P. Burdon et al.
NATURE GENETICS (2011)
Stem Cells and Eye Development
Kang Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group
Daniel F. Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
Michael J. Elman et al.
OPHTHALMOLOGY (2011)
A Phase 1 Study of KH902, a Vascular Endothelial Growth Factor Receptor Decoy, for Exudative Age-Related Macular Degeneration
Ming Zhang et al.
OPHTHALMOLOGY (2011)
Direct reprogramming of mouse fibroblasts to neural progenitors
Janghwan Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Increased expression of multifunctional serine protease, HTRA1, in retinal pigment epithelium induces polypoidal choroidal vasculopathy in mice
Alex Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform
Che-Ming J. Hu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Ciliary neurotrophic factor delivered by encapsulated cell intraocular implants for treatment of geographic atrophy in age-related macular degeneration
Kang Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
CLINICAL FEATURES OF PUNCTATE INNER CHOROIDOPATHY IN CHINESE PATIENTS
Xiongze Zhang et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2011)
Induced Pluripotent Stem Cell Therapies for Geographic Atrophy of Age-Related Macular Degeneration
Hongjun Du et al.
SEMINARS IN OPHTHALMOLOGY (2011)
Current Clinical Trials in Dry AMD and the Definition of Appropriate Clinical Outcome Measures
Zohar Yehoshua et al.
SEMINARS IN OPHTHALMOLOGY (2011)
Agonists at the Serotonin Receptor (5-HT1A) Protect the Retina from Severe Photo-Oxidative Stress
Robert J. Collier et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Effects of Fasudil, a Rho-Associated Protein Kinase Inhibitor, on Optic Nerve Head Blood Flow in Rabbits
Tetsuya Sugiyama et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
Novel ocular antihypertensive compounds in clinical trials
June Chen et al.
CLINICAL OPHTHALMOLOGY (2011)
A Novel Bisretinoid of Retina Is an Adduct on Glycerophosphoethanolamine
Kazunori Yamamoto et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2011)
NANOTECHNOLOGY IN OCULAR DELIVERY: CURRENT AND FUTURE DIRECTIONS
Y. Sultana et al.
DRUGS OF TODAY (2011)
Topical Mecamylamine for Diabetic Macular Edema
Peter A. Campochiaro et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2010)
Nanotechnology in Drug Delivery and Tissue Engineering: From Discovery to Applications
Jinjun Shi et al.
NANO LETTERS (2010)
Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy
Napoleone Ferrara
NATURE MEDICINE (2010)
A novel intracellular protein delivery platform based on single-protein nanocapsules
Ming Yan et al.
NATURE NANOTECHNOLOGY (2010)
Strategies in the design of nanoparticles for therapeutic applications
Robby A. Petros et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Diurnal and Nocturnal Effects of Brimonidine Monotherapy on Intraocular Pressure
John H. K. Liu et al.
OPHTHALMOLOGY (2010)
Ranibizumab for Macular Edema following Central Retinal Vein Occlusion
David M. Brown et al.
OPHTHALMOLOGY (2010)
Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
Michael J. Elman et al.
OPHTHALMOLOGY (2010)
Genome-wide association study of advanced age-related macular degeneration identifies a role of the hepatic lipase gene (LIPC)
Benjamin M. Neale et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
PATHWAY-BASED THERAPIES FOR AGE-RELATED MACULAR DEGENERATION An Integrated Survey of Emerging Treatment Alternatives
Marco A. Zarbin et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2010)
Pharmacologic Vitreolysis
Marc-Andre Rheaume et al.
SEMINARS IN OPHTHALMOLOGY (2010)
Preclinical Evaluation of the Novel Small-Molecule Integrin α5β1 Inhibitor JSM6427 in Monkey and Rabbit Models of Choroidal Neovascularization
Grit Zahn et al.
ARCHIVES OF OPHTHALMOLOGY (2009)
Suppression and Regression of Choroidal Neovascularization by the Multitargeted Kinase Inhibitor Pazopanib
Kyoichi Takahashi et al.
ARCHIVES OF OPHTHALMOLOGY (2009)
Variation near complement factor I is associated with risk of advanced AMD
Jesen A. Fagerness et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2009)
Anti-sphingosine-1-phosphate monoclonal antibodies inhibit angiogenesis and sub-retinal fibrosis in a murine model of laser-induced choroidal neovascularization
Sergio Caballero et al.
EXPERIMENTAL EYE RESEARCH (2009)
Blockade of Sphingosine-1-Phosphate Reduces Macrophage Influx and Retinal and Choroigal Neovascularization
Bing Xie et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
CCR3 is a target for age-related macular degeneration diagnosis and therapy
Atsunobu Takeda et al.
NATURE (2009)
Knocking down barriers: advances in siRNA delivery
Kathryn A. Whitehead et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Comparing Diurnal and Nocturnal Effects of Brinzolamide and Timolol on Intraocular Pressure in Patients Receiving Latanoprost Monotherapy
John H. K. Liu et al.
OPHTHALMOLOGY (2009)
Reduction of endogenous angiogenesis inhibitors in Bruch's membrane of the submacular region in eyes with age-related macular degeneration
Imran A. Bhutto et al.
ARCHIVES OF OPHTHALMOLOGY (2008)
Genetic Susceptibility of Diabetic Retinopathy
Shrena Patel et al.
CURRENT DIABETES REPORTS (2008)
Heritability of proliferative diabetic retinopathy
Kustaa Hietala et al.
DIABETES (2008)
Retinal ganglion cell neuroprotection in a rat model of glaucoma following brimonidine, latanoprost or combined treatments
Maria Hernandez et al.
EXPERIMENTAL EYE RESEARCH (2008)
Retinopathy in mice induced by disrupted all-trans-retinal clearance
Akiko Maeda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated
Shao H. Yang et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Development of prodrug 4-chloro-3-(5-methyl-3-{[4-(2-pyrrolidin-1-ylethoxy)phenyl]amino}1,2,4-benzotriazin-7-yl)phenyl benzoate (TG100801): A topically administered therapeutic candidate in clinical trials for the treatment of age-related macular degeneration
Moorthy S. S. Palanki et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
Mark E. Kleinman et al.
NATURE (2008)
Oxidative damage-induced inflammation initiates age-related macular degeneration
Joe G. Hollyfield et al.
NATURE MEDICINE (2008)
Safety and efficacy of gene transfer for Leber's congenital amaurosis
Albert M. Maguire et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Effect of gene therapy on visual function in Leber's congenital amaurosis
James W. B. Bainbridge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Medical progress: Age-related macular degeneration
Rama D. Jager et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Promoter polymorphism of the erythropoietin gene in severe diabetic eye and kidney complications
Zongzhong Tong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Human gene therapy for RPE65 isomerase deficiency activates the retinoid cycle of vision but with slow rod kinetics
Artur V. Cideciyan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Targeting age-related macular degeneration with Alzheimer's disease based immunotherapies:: Anti-amyloid-β antibody attenuates pathologies in an age-related macular degeneration mouse model
Jin-Dong Ding et al.
VISION RESEARCH (2008)
Nanoparticles in medicine: Therapeutic applications and developments
L. Zhang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Mecamylamine suppresses basal and nicotine-stimulated choroidal neovascularization
Katsuji Kiuchi et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Heritability of the severity of diabetic retinopathy: The FIND-Eye study
Nedal H. Arar et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Potential role of Rho-associated protein kinase inhibitor Y-27632 in glaucoma filtration surgery
Megumi Honjo et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Regulation of fibroblast functions by lysophospholipid mediators: Potential roles in wound healing
Kenneth R. Watterson et al.
WOUND REPAIR AND REGENERATION (2007)
Complement C3 variant and the risk of age-related macular degeneration
John R. W. Yates et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Murine Ccl2/Cx3cr1 deficiency results in retinal lesions mimicking human age-related macular degeneration
Jingsheng Tuo et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2007)
Hypoxia-inducible factor 1α is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif
Stephen C. Land et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Biologic risk factors associated with diabetic retinoplathy - The Los Angeles Latino eye study
Rohit Varma et al.
OPHTHALMOLOGY (2007)
The economic burden of major adult visual disorders in the United States
David B. Rein et al.
ARCHIVES OF OPHTHALMOLOGY (2006)
Challenges and obstacles of ocular pharmacokinetics and drug delivery
Arto Urtti
ADVANCED DRUG DELIVERY REVIEWS (2006)
A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration
Zhenglin Yang et al.
SCIENCE (2006)
Macular degeneration: recent advances and therapeutic opportunities
Amir Rattner et al.
NATURE REVIEWS NEUROSCIENCE (2006)
Corneal avascularity is due to soluble VEGF receptor-1
Balamurali K. Ambati et al.
NATURE (2006)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ranibizumab versus verteporfin for neovascular age-related macular degeneration
David M. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration
Anne E. Hughes et al.
NATURE GENETICS (2006)
The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey
Siv F. E. Nilsson et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2006)
CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration
Mingyao Li et al.
NATURE GENETICS (2006)
Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration
Julian Maller et al.
NATURE GENETICS (2006)
A phase I trial of an IV-administered vascular endothelial growth factor trap for treatment in patients with choroidal neovascularization due to age-related macular degeneration
Quan Dong Nguyen et al.
OPHTHALMOLOGY (2006)
The genetics of age-related macular degeneration: A review of progress to date
Stephen Haddad et al.
SURVEY OF OPHTHALMOLOGY (2006)
Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular enclothelial growth factor therapy in multiple models of ocular neovascularization
Nobuo Jo et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Sustained effect of travoprost on diurnal and nocturnal intraocular pressure
Arthur J. Sit et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2006)
Short-term safety and efficacy of intravitreal bevacizumab (avastin) for neovascular agerelated macular degeneration
Ryan M. Rich et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2006)
Ciliary neurotrophic factor (CNTF) for human retinal degeneration: Phase I trial of CNTF delivered by encapsulated cell intraocular implants
PA Sieving et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Diabetic retinopathy in a multi-ethnic cohort in the United States
TY Wong et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2006)
Drusen complement components C3a and C5a promote choroidal neovascularization
M Nozaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: Characterization, ethnic distribution and evolutionary implications
Gregory S. Hageman et al.
ANNALS OF MEDICINE (2006)
Age-related macular degeneration - emerging pathogenetic and therapeutic concepts
Karen M. Gehrs et al.
ANNALS OF MEDICINE (2006)
Retinal angiogenesis in development and disease
RF Gariano et al.
NATURE (2005)
Roles of extracellular signal-regulated kinase and Akt signaling in coordinating nuclear transcription factor-κB-dependent cell survival after serotonin 1A receptor activation
SC Hsiung et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Efficacy and safety of a fixed combination of travoprost 0.004%/timolol 0.5% ophthalmic solution once daily for open-angle glaucoma or ocular hypertension
JS Schuman et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2005)
Brimonidine and timolol fixed-combination therapy versus monotherapy: A 3-month randomized trial in patients with glaucoma or ocular hypertension
ER Craven et al.
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS (2005)
Relationship between vision impairment and eye disease to vision-specific quality of life and function in rural India: The Aravind Comprehensive Eye Survey
PK Nirmalan et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2005)
A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration
GS Hageman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Effect of CS-088, an angiotensin AT1 receptor antagonist, on intraocular pressure in glaucomatous monkey eyes
RF Wang et al.
EXPERIMENTAL EYE RESEARCH (2005)
Complement factor H polymorphism in age-related macular degeneration
RJ Klein et al.
SCIENCE (2005)
Complement factor H polymorphism and age-related macular degeneration
AO Edwards et al.
SCIENCE (2005)
Complement factor H variant increases the risk of age-related macular degeneration
JL Haines et al.
SCIENCE (2005)
Neuroprotective efficacy of repinotan HCl, a 5-HT1A receptor agonist, in animal models of stroke and traumatic brain injury
F Mauler et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice:: A model for macular degeneration
G Karan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7
V Hornung et al.
NATURE MEDICINE (2005)
Posterior vitreous detachment induced by microplasmin
A Gandorfer et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure.
JHK Liu et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2004)
The 5HT1A receptor agonist, 8-OH-DPAT, protects neurons and reduces astroglial reaction after ischemic damage caused by cortical devascularization
AJ Ramos et al.
BRAIN RESEARCH (2004)
Inhibition of oxygen-induced retinopathy in RTP801-deficient mice
A Brafman et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2004)
Activation of the interferon system by short-interfering RNAs
CA Sledz et al.
NATURE CELL BIOLOGY (2003)
Vascular endothelial growth factor receptor-1 is deposited in the extracellular matrix by endothelial cells and is a ligand for the α5β1 integrin
A Orecchia et al.
JOURNAL OF CELL SCIENCE (2003)
Combretastatin A-4 phosphate suppresses development and induces regression of choroidal neovascularization
H Nambu et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma
YH Yücel et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2003)
Distribution of CNTF receptor a protein in the central nervous system of the chick embryo
S Fuhrmann et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2003)
The biology of VEGF and its receptors
N Ferrara et al.
NATURE MEDICINE (2003)
Ophthalmic drug discovery
AF Clark et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
The G protein-coupled 5-HT1A receptor causes suppression of caspase-3 through MAPK and protein kinase Cα
T Adayev et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2003)
Drusen proteome analysis: An approach to the etiology of age-related macular degeneration
JW Crabb et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
A comparison of the fixed combination of latanoprost and timolol with its individual components
N Pfeiffer
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2002)
The Alzheimer's Aβ-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration
LV Johnson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Medical backgrounders: Glaucoma
FA Medeiros et al.
DRUGS OF TODAY (2002)
Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration
NM Holekamp et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2002)
Latanoprost and timolol combination therapy vs monotherapy - One-year randomized trial
EJ Higginbotham et al.
ARCHIVES OF OPHTHALMOLOGY (2002)
Inhibition of proliferative retinopathy by the anti-vascular agent combretastatin-A4
J Griggs et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Complement activation and inflammatory processes in drusen formation and age related macular degeneration
LV Johnson et al.
EXPERIMENTAL EYE RESEARCH (2001)
An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration
GS Hageman et al.
PROGRESS IN RETINAL AND EYE RESEARCH (2001)
Murine high-fat diet and laser photochemical model of basal deposits in bruch membrane
S Dithmar et al.
ARCHIVES OF OPHTHALMOLOGY (2001)
A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss - AREDS Report No. 8
A Kassoff et al.
ARCHIVES OF OPHTHALMOLOGY (2001)
Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis
RF Mullins et al.
EYE (2001)
A comparison of dorzolamide-timolol combination versus the concomitant drugs
S Choudhri et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2000)
Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration
NL Mata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Glaucoma medical treatment: philosophy, principles and practice
C Migdal
EYE (2000)
分享论文
